CTHRepealedLegislation
National Health (Transitional Arrangements for Opioid Dependence Treatment Medicines) Special Arrangement 2023
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
National Health (Transitional Arrangements for Opioid Dependence Treatment Medicines) Special Arrangement 2023
Start here
Turn the raw legal text into a practical explanation grounded in National Health (Transitional Arrangements for Opioid Dependence Treatment Medicines) Special Arrangement 2023.
This instrument makes a special arrangement for the supply of certain pharmaceutical benefits for the purpose of treating opioid dependence, including for detoxification (withdrawal) and maintenance of withdrawal, by authorised suppliers between 1 July 2023 and 30 June 2024.
The pharmaceutical benefits will be supplied to persons who are receiving treatment by medical practitioners and authorised nurse practitioners.
The authorised suppliers will be persons and organisations who are not approved suppliers but are authorised by States and Territories to supply these pharmaceutical benefits.
This instrument also deals with payments for these supplies of pharmaceutical benefits, payments for other supplies of these pharmaceutical benefits made before 1 July 2023, and administrative matters.
Note 1: Part VII of the Act, and regulations or other instruments made for the purposes of that Part, have effect subject to this instrument (see subsection 100(3) of the Act).
Note 2: For supplies of these pharmaceutical benefits by approved suppliers, see the Listing Instrument and the HSD Special Arrangement.